Biobanking Market Size, Share, and Outlook, H2-2025 Report- By Products and Services (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), By Stora
Description
Biobanking Market Outlook
The global Biobanking Market Size is valued at $77.4 Billion in 2025 and is forecast to reach $126.7 Billion in 2032 at a CAGR of 7.3%.
The Biobanking Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Biobanking Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), By Storage (Manual, Automated), By Ownership (Universities, National/Regional Agencies, Non-Profit Organizations, Private Organizations), By Application (Regenerative Medicine, Life Science Research, Clinical Research), By End-User (Pharmaceutical Companies, Biotechnology Companies, CROs, Research Institutes, Hospitals, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Biobanking Market Insights, 2025
The biobanking market is expanding rapidly as biobanks play a crucial role in supporting translational research, personalized medicine, and clinical trials by providing high-quality biospecimens and associated data. Recent developments focus on automation in sample processing, storage, and retrieval to improve throughput and sample integrity. Advances in digital biobanking platforms enable secure data management, interoperability, and integration with genomic and clinical datasets. Ethical and regulatory frameworks around consent, privacy, and data sharing continue to evolve, ensuring compliance and fostering collaboration. The COVID-19 pandemic underscored the importance of rapid biobanking in infectious disease research and vaccine development. Increasing investments from academic, pharmaceutical, and government institutions bolster infrastructure expansion globally. Novel cryopreservation technologies and room-temperature storage solutions improve specimen viability and reduce costs. Biobanks increasingly support biomarker discovery and precision health initiatives.
Five Trends Shaping the Global Biobanking Market in 2025 and Beyond
The global Biobanking Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Biobanking Industry?
The Biobanking Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Biobanking Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Biobanking Market Segment Insights
The Biobanking Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), By Storage (Manual, Automated), By Ownership (Universities, National/Regional Agencies, Non-Profit Organizations, Private Organizations), By Application (Regenerative Medicine, Life Science Research, Clinical Research), By End-User (Pharmaceutical Companies, Biotechnology Companies, CROs, Research Institutes, Hospitals, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Biobanking Industry Value Chain
The chapter identifies potential companies and their operations across the global Biobanking Industry ecosystem. It assists decision-makers in evaluating global Biobanking Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Biobanking Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Biobanking Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Biobanking Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Biobanking Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Biobanking Market.
Europe Biobanking Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Biobanking Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Biobanking Industry competitiveness. The report analyses the key Biobanking Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Biobanking Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Biobanking Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Biobanking Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Biobanking Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Biobanking Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Biobanking Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AMS Biotechnology Ltd, ASKION GmbH, Avantor Inc, Azenta Inc, Bay Biosciences LLC, Becton, Dickinson and Company, BioKryo GmbH, Cell&Co BioServices SAS, Cryoport Inc, CTIBiotech, Cureline Inc, Firalis Group, Greiner Holding AG, Hamilton Company, Merck KGaA, Micronic Europe B.V., PHC Holdings Corp, ProteoGenex Inc, QIAGEN N.V., Sopachem NV, SPT Labtech Ltd, Tecan Trading AG, Thermo Fisher Scientific Inc, US Biolab Corp Inc, Ziath Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Biobanking Market Scope
Leading Segments
By Products and Services
EquipmentStorage Equipment Sample Analysis Equipment Sample Processing Equipment Sample Transport Equipment
ConsumablesStorage Consumables Analysis Consumables Processing Consumables Collection Consumables
ServicesStorage Services Processing Services Transport Services Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
Leading Companies
AMS Biotechnology Ltd
ASKION GmbH
Avantor Inc
Azenta Inc
Bay Biosciences LLC
Becton, Dickinson and Company
BioKryo GmbH
Cell&Co BioServices SAS
Cryoport Inc
CTIBiotech
Cureline Inc
Firalis Group
Greiner Holding AG
Hamilton Company
Merck KGaA
Micronic Europe B.V.
PHC Holdings Corp
ProteoGenex Inc
QIAGEN N.V.
Sopachem NV
SPT Labtech Ltd
Tecan Trading AG
Thermo Fisher Scientific Inc
US Biolab Corp Inc
Ziath Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Biobanking Market Size is valued at $77.4 Billion in 2025 and is forecast to reach $126.7 Billion in 2032 at a CAGR of 7.3%.
The Biobanking Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Biobanking Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), By Storage (Manual, Automated), By Ownership (Universities, National/Regional Agencies, Non-Profit Organizations, Private Organizations), By Application (Regenerative Medicine, Life Science Research, Clinical Research), By End-User (Pharmaceutical Companies, Biotechnology Companies, CROs, Research Institutes, Hospitals, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Biobanking Market Insights, 2025
The biobanking market is expanding rapidly as biobanks play a crucial role in supporting translational research, personalized medicine, and clinical trials by providing high-quality biospecimens and associated data. Recent developments focus on automation in sample processing, storage, and retrieval to improve throughput and sample integrity. Advances in digital biobanking platforms enable secure data management, interoperability, and integration with genomic and clinical datasets. Ethical and regulatory frameworks around consent, privacy, and data sharing continue to evolve, ensuring compliance and fostering collaboration. The COVID-19 pandemic underscored the importance of rapid biobanking in infectious disease research and vaccine development. Increasing investments from academic, pharmaceutical, and government institutions bolster infrastructure expansion globally. Novel cryopreservation technologies and room-temperature storage solutions improve specimen viability and reduce costs. Biobanks increasingly support biomarker discovery and precision health initiatives.
Five Trends Shaping the Global Biobanking Market in 2025 and Beyond
The global Biobanking Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Biobanking Industry?
The Biobanking Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Biobanking Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Biobanking Market Segment Insights
The Biobanking Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), By Storage (Manual, Automated), By Ownership (Universities, National/Regional Agencies, Non-Profit Organizations, Private Organizations), By Application (Regenerative Medicine, Life Science Research, Clinical Research), By End-User (Pharmaceutical Companies, Biotechnology Companies, CROs, Research Institutes, Hospitals, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Biobanking Industry Value Chain
The chapter identifies potential companies and their operations across the global Biobanking Industry ecosystem. It assists decision-makers in evaluating global Biobanking Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Biobanking Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Biobanking Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Biobanking Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Biobanking Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Biobanking Market.
Europe Biobanking Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Biobanking Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Biobanking Industry competitiveness. The report analyses the key Biobanking Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Biobanking Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Biobanking Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Biobanking Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Biobanking Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Biobanking Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Biobanking Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AMS Biotechnology Ltd, ASKION GmbH, Avantor Inc, Azenta Inc, Bay Biosciences LLC, Becton, Dickinson and Company, BioKryo GmbH, Cell&Co BioServices SAS, Cryoport Inc, CTIBiotech, Cureline Inc, Firalis Group, Greiner Holding AG, Hamilton Company, Merck KGaA, Micronic Europe B.V., PHC Holdings Corp, ProteoGenex Inc, QIAGEN N.V., Sopachem NV, SPT Labtech Ltd, Tecan Trading AG, Thermo Fisher Scientific Inc, US Biolab Corp Inc, Ziath Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Biobanking Market Scope
Leading Segments
By Products and Services
Equipment
Consumables
Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
Leading Companies
AMS Biotechnology Ltd
ASKION GmbH
Avantor Inc
Azenta Inc
Bay Biosciences LLC
Becton, Dickinson and Company
BioKryo GmbH
Cell&Co BioServices SAS
Cryoport Inc
CTIBiotech
Cureline Inc
Firalis Group
Greiner Holding AG
Hamilton Company
Merck KGaA
Micronic Europe B.V.
PHC Holdings Corp
ProteoGenex Inc
QIAGEN N.V.
Sopachem NV
SPT Labtech Ltd
Tecan Trading AG
Thermo Fisher Scientific Inc
US Biolab Corp Inc
Ziath Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
191 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Biobanking Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Biobanking Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Biobanking Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Biobanking Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Biobanking Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Products and Services
- Equipment
- -Storage Equipment
- -Sample Analysis Equipment
- -Sample Processing Equipment
- -Sample Transport Equipment
- Consumables
- -Storage Consumables
- -Analysis Consumables
- -Processing Consumables
- -Collection Consumables
- Services
- -Storage Services
- -Processing Services
- -Transport Services
- -Supply Services
- Software
- By Sample Type
- Blood Products
- Human Tissues
- Cell Lines
- Nucleic Acids
- Biological Fluids
- Human Waste Products
- By Storage
- Manual
- Automated
- By Ownership
- Universities
- National/Regional Agencies
- Non-Profit Organizations
- Private Organizations
- By Application
- Regenerative Medicine
- Life Science Research
- Clinical Research
- By End-User
- Pharmaceutical Companies
- Biotechnology Companies
- CROs
- Research Institutes
- Hospitals
- Others
- 6. Global Biobanking Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Biobanking Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Biobanking Market Trends and Growth Opportunities
- 6.2.1 North America Biobanking Market Outlook by Type
- 6.2.2 North America Biobanking Market Outlook by Application
- 6.3 North America Biobanking Market Outlook by Country
- 6.3.1 The US Biobanking Market Outlook, 2021- 2032
- 6.3.2 Canada Biobanking Market Outlook, 2021- 2032
- 6.3.3 Mexico Biobanking Market Outlook, 2021- 2032
- 7. Europe Biobanking Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Biobanking Market Trends and Growth Opportunities
- 7.2.1 Europe Biobanking Market Outlook by Type
- 7.2.2 Europe Biobanking Market Outlook by Application
- 7.3 Europe Biobanking Market Outlook by Country
- 7.3.2 Germany Biobanking Market Outlook, 2021- 2032
- 7.3.3 France Biobanking Market Outlook, 2021- 2032
- 7.3.4 The UK Biobanking Market Outlook, 2021- 2032
- 7.3.5 Spain Biobanking Market Outlook, 2021- 2032
- 7.3.6 Italy Biobanking Market Outlook, 2021- 2032
- 7.3.7 Russia Biobanking Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Biobanking Market Outlook, 2021- 2032
- 8. Asia Pacific Biobanking Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Biobanking Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Biobanking Market Outlook by Type
- 8.2.2 Asia Pacific Biobanking Market Outlook by Application
- 8.3 Asia Pacific Biobanking Market Outlook by Country
- 8.3.1 China Biobanking Market Outlook, 2021- 2032
- 8.3.2 India Biobanking Market Outlook, 2021- 2032
- 8.3.3 Japan Biobanking Market Outlook, 2021- 2032
- 8.3.4 South Korea Biobanking Market Outlook, 2021- 2032
- 8.3.5 Australia Biobanking Market Outlook, 2021- 2032
- 8.3.6 South East Asia Biobanking Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Biobanking Market Outlook, 2021- 2032
- 9. South America Biobanking Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Biobanking Market Trends and Growth Opportunities
- 9.2.1 South America Biobanking Market Outlook by Type
- 9.2.2 South America Biobanking Market Outlook by Application
- 9.3 South America Biobanking Market Outlook by Country
- 9.3.1 Brazil Biobanking Market Outlook, 2021- 2032
- 9.3.2 Argentina Biobanking Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Biobanking Market Outlook, 2021- 2032
- 10. Middle East and Africa Biobanking Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Biobanking Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Biobanking Market Outlook by Type
- 10.2.2 Middle East and Africa Biobanking Market Outlook by Application
- 10.3 Middle East and Africa Biobanking Market Outlook by Country
- 10.3.1 Saudi Arabia Biobanking Market Outlook, 2021- 2032
- 10.3.2 The UAE Biobanking Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Biobanking Market Outlook, 2021- 2032
- 10.3.4 South Africa Biobanking Market Outlook, 2021- 2032
- 10.3.5 Egypt Biobanking Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Biobanking Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- AMS Biotechnology Ltd
- ASKION GmbH
- Avantor Inc
- Azenta Inc
- Bay Biosciences LLC
- Becton, Dickinson and Company
- BioKryo GmbH
- Cell&Co BioServices SAS
- Cryoport Inc
- CTIBiotech
- Cureline Inc
- Firalis Group
- Greiner Holding AG
- Hamilton Company
- Merck KGaA
- Micronic Europe B.V.
- PHC Holdings Corp
- ProteoGenex Inc
- QIAGEN N.V.
- Sopachem NV
- SPT Labtech Ltd
- Tecan Trading AG
- Thermo Fisher Scientific Inc
- US Biolab Corp Inc
- Ziath Ltd
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
